AMR Logo.png
Urinary Tract Cancer Market Predicted to Swell $8.7 billion by 2030, Exclusive Report by Allied Market Research
October 07, 2021 09:38 ET | Allied Market Research
Portland, OR, Oct. 07, 2021 (GLOBE NEWSWIRE) -- According to the report published by Portland-based research firm Allied Market Research, the global urinary tract cancer market generated $1.7...
vmr logo TM.png
Branded Generics Market size worth $ 535.8 Billion, Globally, by 2028 at 7.73% CAGR: Verified Market Research®
September 28, 2021 10:15 ET | Verified Market Research
Jersey City, New Jersey, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Branded Generics Market” By Type (Trade Named Generics, and Value-Added Branded...
Bruce Power receives regulatory approval for new lifesaving medical isotope production
September 24, 2021 15:14 ET | Bruce Power
Tiverton, Ontario, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Bruce Power has received approval from the Canadian Nuclear Safety Commission (CNSC) to take the next step forward for new isotope production...
New Technology at Mary Bird Perkins Set to Revolutionize Cancer Treatment in Baton Rouge and Across Gulf South
September 22, 2021 11:00 ET | Mary Bird Perkins Cancer Center
BATON ROUGE, LA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- As Mary Bird Perkins Cancer Center celebrates its 50th anniversary, the organization is announcing a new, transformational development solidifying...
anpac_logo_full color_stacked.png
AnPac Bio and Roche Pharmaceuticals China Entered into Cooperation to Explore Innovative Healthcare and Medical Solutions
August 05, 2021 07:30 ET | Anpac Bio, USA
PHILADELPHIA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
anpac_logo_full color_stacked.png
AnPac Bio Began Generating Contract Medical Device R&D Revenue
July 21, 2021 06:30 ET | Anpac Bio, USA
PHILADELPHIA, July 21, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
LIXTE.jpg
Lixte Biotechnology to Present its Drug Development Pipeline for Cancer Treatment at The MoneyShow Virtual Expo on July 14, 2021
July 07, 2021 09:35 ET | Lixte Biotechnology Holdings, Inc.
Presentation to highlight Company’s current clinical study of lead compound LB-100 for Small Cell Lung Cancer ALTADENA, CA, July 07, 2021 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc....
visiongain Logo.png
European Antibiotics Market Size Worth US$17,778.6 Million by 2031: Visiongain Research, Inc.
July 01, 2021 12:00 ET | Visiongain Ltd
Visiongain has published a new report on “European Antibiotics Market 2021-2031”. Forecasts by Drug Class (Cephalosporin, Fluoroquinolone, Penicillin, Carbapenem, Macrolide, Sulfonamide, Amino...
visiongain Logo.png
Cancer Diagnostics Market worth US$1,16,276.2 Million in 2031: Visiongain Research Inc.
June 21, 2021 11:30 ET | Visiongain Ltd
Visiongain has published a new report on “Cancer Diagnostics Market Forecast of 2021 to 2031”. Forecasts by Test Type {(Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, BRCA Tests, CA-19...
anpac_logo_full color_stacked.png
AnPac Bio’s First Disease Treatment Patent Granted, and Its Cancer Treatment Project Secured Multi-Million Dollar Funds
June 18, 2021 06:30 ET | Anpac Bio, USA
PHILADELPHIA, June 18, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...